Crosstalk between cyclophilins and T lymphocytes in coronary artery disease

Sandra Gegunde1, Amparo Alfonso1, Rebeca Alvariño1

  • 1Departamento de Farmacología, Facultad de Veterinaria, Universidad de Santiago de Compostela, Lugo, 27002, Spain; Grupo Investigación Biosdiscovery, IDIS, Spain.

Experimental Cell Research
|February 14, 2021
PubMed

Insights

Cyclophilins and their receptor CD147 are elevated in patients with coronary artery disease, suggesting a role in inflammation and disease progression. This finding highlights potential therapeutic targets for cardiovascular disease.

Area of Science:

  • Cardiology
  • Immunology
  • Biochemistry

Background:

  • Cardiovascular diseases, including coronary artery disease (CAD) and atherosclerosis, are major global health issues.
  • Systemic and local inflammation are increasingly recognized as key contributors to CAD pathogenesis.
  • Cyclophilins and their receptor CD147 are implicated in inflammatory processes, but their specific role in cardiovascular disease remains unclear.

Purpose of the Study:

  • To investigate the physiological relevance of cyclophilins and the CD147 receptor in cardiovascular artery disease.
  • To elucidate the relationship between cyclophilins, inflammation, and CAD.
  • To assess cyclophilin and interleukin levels in patients with varying CAD status.

Main Methods:

  • Serum samples from 30 subjects (10 acute coronary syndrome, 10 chronic CAD, 10 controls) were analyzed.
  • Cyclophilins (A, B, C) and pro-inflammatory interleukins were quantified in serum.
  • Cyclophilin levels and CD147 receptor expression were measured in purified T lymphocytes.

Main Results:

  • Cyclophilin A, B, and C levels were significantly elevated in CAD patients compared to controls.
  • Pro-inflammatory interleukins were significantly higher in patients with CAD.
  • CD147 membrane expression on T lymphocytes was also significantly increased in CAD patients.

Conclusions:

  • Elevated cyclophilins and CD147 expression in CAD patients suggest their involvement in cardiovascular disease pathogenesis.
  • These findings indicate a potential link between cyclophilins, inflammation, and the progression of coronary artery disease.
  • Cyclophilins and CD147 may represent novel therapeutic targets for managing cardiovascular inflammatory conditions.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
184
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
156
Inflammation01:38

Inflammation

Overview
57.6K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
660
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
149
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.7K